HB413 Alabama 2010 Session

Summary

Primary Sponsor

Rod Scott

Democrat

Co-Sponsors

Jim BartonJim McClendonJamie IsonSteve McMillanChad FincherJoe FaustHarry ShiverJimmy MartinJoe HubbardGerald H. AllenDickie DrakeJack WilliamsMike BallVictor GastonJay LoveSteve ClouseBarry MaskElaine BeechMary Sue McClurkinWarren BeckAlan BootheRichard J. LairdCharles O. NewtonAllen TreadawaySpencer CollierRobert BentleyGreg WrenMicky HammonPhil WilliamsDavid GrimesHoward SanderfordDuwayne BridgesGregory CanfieldMac McCutcheonAlan HarperMike MillicanJody LetsonMike CurtisYvonne KennedyOliver RobinsonThad McClammyRalph HowardPebblin W. WarrenJames O. GordonDemetrius C. NewtonYusuf SalaamRandy HinshawTerry SpicerLaura HallBill J. DukesWilliam “Bill” M. BeasleyMike HillH. Mac GipsonRandy DavisCraig FordElwyn ThomasJohnny Mack MorrowPatricia ToddJohn RobinsonJames C. FieldsWilliam E. ThigpenButch TaylorHenry A. WhiteTommy ShererJames E. BuskeySteve HurstTammy Irons

Session

Regular Session 2010

Title

Ephedrine, pseudoephedrine, and phenylpropanolamine, State Board of Health required to classify as controlled substances, exemptions, removed from list of precursor chemicals maintained by State Board of Pharmacy, Secs. 20-2-20, 20-2-181 am'd.

Description

Under existing law, controlled substances may only be sold by prescription. Under existing law, the State Board of Health has the authority to add, delete, or reschedule substances as controlled substances, but the board must exclude a nonnarcotic substance from a schedule if the substance may lawfully be sold over the counter without a prescription pursuant to federal law.

This bill would allow ephedrine, pseudoephedrine, and phenylpropanolamine to be sold by prescription by requiring the State Board of Health to classify the drugs as Schedule III controlled substances. This bill would give the board the authority to exempt a product containing any of these substances from classification as a controlled substance if the board finds that the product is effectively formulated to prevent conversion of the active ingredient into methamphetamine or its salts or precursors. This bill would also authorize the board to revoke the exemption upon notification from the Department of Public Safety that the product exempted is not effectively formulated to prevent its conversion to methamphetamine.

Show more Show less

Subjects

Controlled Substances